Docetaxel, cisplatin, and 5-fluorouracil
โ
Robert Haddad; A. Dimitrios Colevas; Roy Tishler; Paul Busse; Laura Goguen; Chri
๐
Article
๐
2003
๐
John Wiley and Sons
๐
English
โ 86 KB
๐ 2 views
## Abstract ## BACKGROUND The authors conducted a series of four Phase IโII trials of highโdose and intermediateโdose docetaxel, cisplatin, and 5โfluorouracil (TPF)โbased induction chemotherapy for patients with advanced squamous cell carcinoma of the head and neck (SCCHN). The chemotherapy regime